M&R Capital Management Inc. decreased its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 6.8% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 22,698 shares of the healthcare product maker’s stock after selling 1,666 shares during the quarter. M&R Capital Management Inc.’s […]